Updated Jul 16, 2026
PAPA JOSEPH C has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $350K.

Joseph C. Papa is a seasoned executive in the biopharmaceutical industry, currently serving as the President and CEO of Milestone Pharmaceuticals Inc. He has held various leadership roles across multiple companies, focusing on the development and commercialization of innovative therapies.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-01 | EBS | Emergent BioSolutions Inc. | A — Grant or award | 187.7K | $0.00 | |
| 2026-03-06 | EBS | Emergent BioSolutions Inc. | F — Tax withholding / forfeiture | 37.1K | $8.44 | $313K |
| 2025-07-11 | MIST | Milestone Pharmaceuticals Inc. | A — Grant or award | 100.0K | — | |
| 2025-06-25 | CADL | Candel Therapeutics, Inc. | A — Grant or award | 64.2K | $4.67 | $300K |
| 2025-05-13 | EBS | Emergent BioSolutions Inc. | P — Open-market purchase | 60.0K | $5.83 | $350K |
Joseph C. Papa is a seasoned executive in the biopharmaceutical industry, currently serving as the President and CEO of Milestone Pharmaceuticals Inc. He has held various leadership roles across multiple companies, focusing on the development and commercialization of innovative therapies.…
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 1 open-market purchases ($350K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PAPA JOSEPH C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.